Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19

Jiuxin Qu1, Zhao Cai2, Xiangke Duan2

  • 1Department of Clinical Laboratory, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Guangdong Provincial Clinical Research Center for Infectious Diseases (Tuberculosis), National Clinical Research Center for Infectious Diseases, Shenzhen, 518000, Guangdong, China.

Cell & Bioscience
|February 10, 2022
PubMed
Abstract

Insights

COVID-19 lung infections promote bacterial adaptation, enabling pathogens like Pseudomonas aeruginosa to form biofilms and evade immune responses, leading to chronic infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genomics

Background:

  • COVID-19 pneumonia leads to high morbidity and mortality.
  • Viral infections disrupt lung microbial ecology, increasing susceptibility to bacterial superinfections.
  • Bacterial superinfections complicate COVID-19 treatment and disease progression.

Purpose of the Study:

  • Investigate bacterial adaptation in the lung microenvironment of COVID-19 patients.
  • Understand the mechanisms of bacterial superinfection during COVID-19.
  • Identify genetic traits facilitating chronic infections post-SARS-CoV-2.

Main Methods:

  • Sequencing analysis of Pseudomonas aeruginosa strains.
  • Phenotypic assays to assess bacterial adaptation.
  • Macrophage cytotoxicity and reactive oxygen species measurements.

Main Results:

  • Adapted P. aeruginosa strains exhibited increased alginate biosynthesis and reduced type VI secretion system (T6SS) activity.
  • These adaptations resulted in excessive biofilm formation and reduced virulence.
  • Adapted strains showed enhanced evasion of host immune clearance compared to ancestral strains.

Conclusions:

  • SARS-CoV-2 infection creates a lung environment conducive to rapid bacterial evolution.
  • Bacterial pathogens can acquire traits suitable for chronic infections following viral pneumonia.
  • Understanding these adaptive mechanisms is crucial for managing superinfections in COVID-19 patients.